Super-Responders and Non-Responders to CGRP Monoclonal Antibodies in the Treatment of Migraine

被引：0
|
作者：
Shadbehr, N. [1 ]
Lee, M. [1 ]
Patel, P. [1 ]
George, N. [2 ]
Hanidu, I [3 ]
Tariq, H. [4 ]
Bucklan, J. N. [3 ]
Kriegler, J. S. [1 ]
Mays, M. [1 ]
Ahmed, Z. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Med Ctr, Rocky River, OH USA
[3] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Case Western Reserve Univ, Parma, OH USA
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [1] Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
    Bianca Raffaelli
    Mira Fitzek
    Lucas H. Overeem
    Elisabeth Storch
    Maria Terhart
    Uwe Reuter
    The Journal of Headache and Pain, 24
  • [2] Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
    Raffaelli, Bianca
    Fitzek, Mira
    Overeem, Lucas H.
    Storch, Elisabeth
    Terhart, Maria
    Reuter, Uwe
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [3] Clinical characteristics of non-responders and super-responders
    Hua, Wei
    CIRCULATION, 2012, 125 (19) : E720 - E720
  • [4] Galcanezumab effects on incidence of headache after occurrence of triggers, prodromes, and aura in responders, non-responders, super-responders and super non-responders
    Ashina, Sait
    Carrillo, Agustin Melo
    Ajayi, Toluwanimi
    Szabo, Edina
    Borsook, David
    Burstein, Rami
    NEUROLOGY, 2023, 100 (17)
  • [5] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Sait Ashina
    Agustin Melo-Carrillo
    Ajayi Toluwanimi
    Nicolas Bolo
    Edina Szabo
    David Borsook
    Rami Burstein
    The Journal of Headache and Pain, 24
  • [6] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Ashina, Sait
    Melo-Carrillo, Agustin
    Toluwanimi, Ajayi
    Bolo, Nicolas
    Szabo, Edina
    Borsook, David
    Burstein, Rami
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [7] Home monitoring insights into cardiac resynchronisation super-responders vs non-responders
    Brown, Stewart
    Dayer, Mark
    Furniss, Guy
    HEART, 2023, 109 : A121 - A123
  • [8] Monoclonal Antibodies (mAB) for Migraine as a Potential Treatment for Botox Non-responders in Brazil
    Krymchantowski, A., V
    Jevoux, C.
    HEADACHE, 2018, 58 : 120 - 120
  • [9] Differential Regulation of Metabolic Parameters between Super-Responders and Non-Responders Treated With Sitagliptin
    Kutoh, Eiji
    Ukai, Yasuhiro
    DIABETES, 2013, 62 : A274 - A275
  • [10] Psychological profiles of super responders and non-responders to CGRP-monoclonal antibodies: data from a 6-month follow-up
    Bottiroli, S.
    Vaghi, G.
    De Icco, R.
    Martinelli, D.
    Pocora, M. M.
    Sances, G.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
12345